Colorado’s controlled substance prescription laws combine federal DEA rules with state-specific limits: an initial opioid prescription is capped at a seven-day supply, prescribers must check the state Prescription Drug Monitoring Program before writing opioids or benzodiazepines, and every controlled substance prescription must serve a legitimate medical purpose. Violations range from a level 2 drug misdemeanor for simple unlawful possession up to a level 1 drug felony carrying 8 to 32 years in prison for unlawful distribution.
Who Can Prescribe in Colorado
A Colorado prescriber needs an active state professional license and a federal DEA registration before writing a single controlled substance prescription. DEA registration is obtained through Form 224 and lasts three years.1reginfo.gov. DEA Form 224 – Application for Registration Under the Controlled Substances Act
Since June 2023, the MATE Act adds a one-time training requirement. Every DEA-registered prescriber other than veterinarians must attest to completing at least eight hours of training on treating substance use disorders or on safe pain management. The attestation happens at the next registration or renewal and does not repeat in later cycles.2Diversion Control Division. Opioid Use Disorder – MATE Act Q&A
Core Prescribing Rules
Federal law requires every controlled substance prescription to be issued for a legitimate medical purpose by a practitioner acting in the usual course of professional practice. A pharmacist who knowingly fills a prescription that fails that test is on the hook alongside the prescriber.3eCFR. 21 CFR Part 1306 – Prescriptions
The Colorado Medical Board expects prescribers to evaluate the patient’s medical history, consider non-opioid alternatives for chronic pain, set clear treatment goals, and review progress at intervals. Documentation of each step belongs in the patient record, and tools like urine drug testing should be used to monitor compliance with the regimen.
The Seven-Day Cap on New Opioid Prescriptions
Colorado caps an initial opioid prescription at a seven-day supply when the patient has not received an opioid from that prescriber within the past twelve months. The prescriber may authorize one additional seven-day fill beyond the initial supply.4Justia Law. Colorado Code 12-30-109 – Prescriptions – Limitations – Definition – Rules Cancer treatment, hospice care, and certain chronic pain situations are carved out.
Schedule II Prescriptions
Schedule II drugs, including oxycodone, fentanyl, and amphetamine-based stimulants, cannot be refilled. Each fill needs a new prescription. If a pharmacist cannot supply the full quantity, the remainder must be filled within 72 hours or the prescription expires. Long-term care residents and patients with a terminal illness diagnosis get a longer window: partial fills stay valid for up to 60 days from the issue date.5eCFR. 21 CFR Part 1306 – Controlled Substances Listed in Schedule II
A practitioner may issue multiple Schedule II prescriptions at one visit for up to a 90-day total supply, provided the individual prescriptions carry staggered fill dates and the arrangement complies with state law. Schedule III and IV prescriptions allow up to five refills within six months of the date written.6Office of the Law Revision Counsel. 21 USC 829 – Prescriptions
Telehealth Prescribing Through 2026
The Ryan Haight Act normally requires at least one in-person evaluation before a practitioner can prescribe controlled substances remotely. COVID-era flexibilities have been repeatedly extended, and through December 31, 2026, DEA-registered practitioners may prescribe Schedule II through V substances via telehealth without a prior in-person visit if they meet the conditions the DEA has set.7Federal Register. Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications The flexibility expires at the end of 2026, so watch for DEA rulemaking on a permanent framework.
The PDMP Check and Electronic Prescribing
Colorado’s Prescription Drug Monitoring Program is a statewide electronic database tracking every dispensed controlled substance prescription.8Divisions of Professions and Occupations. About the Colorado PDMP State law requires prescribers to query the PDMP before writing certain controlled substance prescriptions, particularly opioids and benzodiazepines, to review the patient’s recent prescription history.9Justia Law. Colorado Code 12-280-403 – Prescription Drug Electronic Program Registered prescribers and pharmacists may authorize up to three members of their healthcare team to access the system on their behalf. Because Colorado’s PDMP integrates with programs in other states, a patient’s out-of-state fills show up in the check.
Federal law also requires that Schedule II through V prescriptions for Medicare Part D patients be transmitted electronically rather than by paper or fax. A printed prescription generated by an EHR does not count as electronic prescribing. Prescribers must transmit at least 70 percent of their Medicare Part D controlled substance prescriptions electronically each measurement year to remain compliant.10Centers for Medicare & Medicaid Services (CMS). Frequently Asked Questions – EPCS Program
Storage, Recordkeeping, and Theft Reporting
Controlled substances must be kept in securely locked, substantially built cabinets or safes. Records of every controlled substance received, prescribed, dispensed, or disposed of must be maintained with the substance name, quantity, transaction date, and patient identity. Colorado requires those records to be retained for at least two years, and DEA regulations may require longer retention for certain substances.11Justia Law. Colorado Code 18-18-302
Federal law also requires every DEA registrant to conduct a complete physical inventory of on-hand controlled substances at least once every two years. The biennial inventory can be taken on any date within two years of the previous one, and discrepancies between the books and the shelf are what draws DEA scrutiny.12eCFR. 21 CFR 1304.11 – Inventory Requirements
When controlled substances are stolen or significantly lost, two reporting duties trigger. The practitioner must notify the DEA Field Division Office in writing within one business day of discovery, and must submit a complete DEA Form 106 electronically within 45 calendar days. Paper Form 106 submissions are no longer accepted.13Federal Register. Reporting Theft or Significant Loss of Controlled Substances
Federal civil penalties for recordkeeping violations under the Controlled Substances Act can reach $82,950 per violation under 2025 adjustments, and incomplete or falsified records can prompt Colorado Medical Board investigations independently.14eCFR. 28 CFR Part 85 – Civil Monetary Penalties Inflation Adjustment
Criminal Penalties
Colorado sorts controlled substance offenses into drug felony levels 1 through 4 and drug misdemeanor levels 1 and 2, each with its own sentencing range.
Prescription Fraud
Obtaining a controlled substance through fraud, deceit, misrepresentation, or a forged prescription is a level 4 drug felony under C.R.S. § 18-18-415. So is affixing a false label to a package containing a controlled substance.15Justia Law. Colorado Code 18-18-415 A level 4 drug felony carries a presumptive sentence of 6 months to 1 year in prison, fines of $1,000 to $100,000, and one year of mandatory parole. Aggravating factors, such as the offense being part of a pattern of distribution, can raise the sentence to 1 to 2 years with fines up to $1,000,000.16Colorado Department of Human Services. Felony Sentencing Guidelines
The statute reaches the scenarios prosecutors see most often: altering a legitimate prescription to increase the quantity, using someone else’s identity to obtain medications, visiting multiple doctors to collect overlapping prescriptions, and calling in fake prescriptions to pharmacies.
Unlawful Distribution and Dispensing
Manufacturing, distributing, dispensing, or possessing controlled substances with intent to distribute is charged under C.R.S. § 18-18-405, with penalties that scale by the schedule and quantity involved. The statute reaches practitioners who prescribe outside legitimate medical practice as squarely as it reaches street-level distribution.17Justia Law. Colorado Code 18-18-405 – Unlawful Distribution, Manufacturing, Dispensing, or Sale The sentencing ranges:
- Level 1 drug felony: 8 to 32 years in prison, fines of $5,000 to $1,000,000, and 3 years of mandatory parole. Reserved for the most serious offenses involving large quantities or especially dangerous substances.
- Level 2 drug felony: 4 to 8 years in prison, fines of $3,000 to $750,000, and 2 years of mandatory parole.
- Level 3 drug felony: 2 to 4 years in prison, fines of $2,000 to $500,000, and 1 year of mandatory parole.
- Level 4 drug felony: 6 months to 1 year in prison, fines of $1,000 to $100,000, and 1 year of mandatory parole.
Each level has an aggravated range that applies when factors such as using a weapon, involving a minor, or committing the offense while on parole for another felony are present.16Colorado Department of Human Services. Felony Sentencing Guidelines
Simple Possession or Use
Possessing or using a controlled substance without a valid prescription is a level 2 drug misdemeanor under C.R.S. § 18-18-404, carrying a fine of $50 to $750, up to 364 days in jail, or both.18Justia Law. Colorado Code 18-18-404 – Unlawful Use of a Controlled Substance Level 1 drug misdemeanors, covering more serious misdemeanor conduct, range from 6 to 18 months in jail with fines of $500 to $5,000.19Colorado Department of Human Services. Misdemeanor Sentencing Guidelines
Professional Discipline
Prescribers who violate controlled substance laws also face the Colorado Medical Board under C.R.S. § 12-240-125. Consequences include license suspension or revocation, mandated additional training, practice restrictions, and civil fines. A criminal conviction is not required. An investigation showing improper prescribing practices or recordkeeping failures is enough on its own.20Justia Law. Colorado Code 12-240-125
Ending a Prescription Without Abandoning the Patient
When a prescriber discontinues a controlled substance, Colorado law expects continuity of care, particularly for patients with chronic conditions or dependency risks. Abruptly cutting off medication without proper steps can amount to patient abandonment.
Standard practice is to give the patient adequate notice (typically 30 days) to arrange alternative care and to offer referrals to other practitioners or addiction treatment programs when appropriate. Skipping those steps can draw Colorado Medical Board discipline.20Justia Law. Colorado Code 12-240-125
An exception applies when the prescriber suspects the patient is misusing or diverting the medication. The prescription can be terminated immediately in that situation. The prescriber must document the reasons in the record and, when appropriate, report the concern to law enforcement or the Colorado PDMP. Providing the patient with information about addiction treatment resources remains the responsible course to reduce the risk of withdrawal complications.
Safe Disposal of Unused Medications
Federal regulations authorize several ways for patients to dispose of unused Schedule II through V medications:21eCFR. 21 CFR Part 1317 – Disposal
- Collection receptacles at pharmacies, hospitals, and police stations run by authorized collectors and law enforcement, where you drop off medications without providing personal information.
- Mail-back programs using prepaid, preaddressed envelopes from authorized collectors or law enforcement, with no personally identifiable information required.
- DEA National Prescription Drug Take Back Day events held twice a year. The next scheduled event is April 25, 2026, from 10 a.m. to 2 p.m. at collection sites nationwide.22Diversion Control Division. National Prescription Drug Take Back Day
Long-term care facilities have an additional option: the facility can transfer a resident’s unused medications into an authorized collection receptacle on the resident’s behalf. Flushing is discouraged for most substances, though the FDA maintains a short list of medications where flushing is recommended because the risk of accidental exposure is high.